Full-Time

Clinical Account Associate

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

Healthcare technology using AI for patient outcomes

No salary listed

Entry, Junior

Company Historically Provides H1B Sponsorship

Reno, NV, USA

Category
Customer Success
Sales & Account Management
Required Skills
Sales
Customer Service
Requirements
  • Demonstrate the capacity to quickly learn relevant genomic and oncology information
  • Ability to work independently, communicate proactively, manage multiple projects and prioritize daily tasks while managing critical deadlines
  • Ability to maintain an outstanding level of market, customer, and product knowledge necessary to support sales objectives
  • Excellent customer service skills and ability to connect with healthcare professionals
  • Possess a very positive attitude and an understanding of the dynamics involved with organizational growth and change
  • Strong administrative skills and sophistication to manage business in complex environments
  • Demonstrate Tempus’ Values by acting with integrity, respect and trust
  • Travel throughout the territory as needed
Responsibilities
  • Work with the Clinical Account Executive CAE on plans for gaining and retaining new and existing clients
  • Collaborate and coordinate with all sales positions (VP, Sales, RSD’s, DSM’s, SAM’s, and GL’s) to ensure successful attainment of company goals and objectives
  • Identify opportunities with existing customers on the use of Tempus algorithmic tests and add ons. These will include but not limited to HRD, TO, DPYD, UGT1A1, PURist
  • Collaborate with Clinical Account Executives on upsell opportunities for various products
  • Drive customer adoption of online ordering through the Tempus Hub and EMR integrations
  • Identify and develop partnering opportunities between prospective oncology clients and Tempus
  • Promote and drive compliance with new web-based molecular information tools for all clients
  • Continually analyze competitive landscape and environment within assigned accounts to determine trends and provide customer feedback to Tempus leadership
  • Monitor performance of sales to ensure objectives are met
  • Develop and implement a comprehensive business plan for the territory that will be inclusive of budgets, travel, territory management, goal setting, etc.
  • Embrace, embody and represent the Tempus company culture at all times to external and internal constituents
  • Building and maintaining relationships with physicians and office staff to drive clinical orders in the community
  • Building and maintaining relationships with pathology departments to ensure smooth specimen sendouts - tissue procurement
  • Maintain a regular cadence of touch points (in person, emailing value adds) with certain targeted accounts (ie 3 x month per physician)
  • Coordinating Medical Affairs report review with physicians after clinical orders
  • Order Kit and literature replenishment at accounts
  • Identifying and attending approved local conferences
  • Working with accounts to obtain necessary clinical data / progress notes for Tempus-tested patients
Desired Qualifications
  • B.S. in biology, life science, business or marketing
  • Sales support experience in healthcare (preferably oncology or pathology) with a history of proven past performance, meeting or exceeding expectations
  • OR general clinical experience

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Deep 6 AI expands Tempus' data network and precision medicine capabilities.
  • Partnership with Stemline Therapeutics strengthens Tempus' position in personalized cancer treatment.
  • Collaboration with Artera expands Tempus' reach in oncology diagnostics.

What critics are saying

  • Integration challenges with Deep 6 AI may lead to operational inefficiencies.
  • $560 million debt increases financial leverage, posing a risk if growth falters.
  • Regulatory hurdles may arise in expanding DNA profiling beyond cancer with Illumina.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids in personalized cancer treatment through advanced data insights.
  • Tempus collaborates with leading biotech firms to enhance drug development processes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
SDBN
Apr 15th, 2025
Illumina teams up with Tempus to expand DNA profiling beyond cancer

Illumina teams up with Tempus to expand DNA profiling beyond cancer.

Life Care News
Mar 30th, 2025
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

Tempus exhibits 4 abstracts at the 2025 American College of Cardiology Annual Meeting.

Tempus
Mar 12th, 2025
Tempus Announces Acquisition of Deep 6 AI | Tempus AI

Deep 6 is integrated with over 750 provider site locations spanning more than 30 million patients, which will materially add to Tempus’ existing network CHICAGO --(BUSINESS WIRE)--Mar. 11, 2025-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision

TipRanks
Mar 12th, 2025
Tempus AI (TEM) Strengthens Precision Medicine with Deep 6 AI Deal, Cathie Wood Buys the Dip

Tempus AI has acquired Deep 6 AI to expand its reach and enhance offerings in precision medicine.

Business Wire
Feb 25th, 2025
Ares Management Upsizes Tempus Debt Facilities to $560 Million

Combined with $260 million of capital provided in 2022 and 2023, Ares Credit funds have provided Tempus a total debt package of approximately $560 million.